The U.S. continuous positive airway pressure devices market size was estimated at USD 1.35 billion in 2025 and is projected to reach USD 2.07 billion by 2033, growing at a CAGR of 5.50% from 2026 to 2033. This is attributed to the rising prevalence of sleep apnea and respiratory disorders, technological advancements in continuous positive airway pressure devices (CPAP) devices, growing awareness and diagnosis of sleep apnea, and favorable reimbursement policies.
For instance, Medicare covers a 3-month trial of CPAP devices and accessories for individuals diagnosed with obstructive sleep apnea. The incidence of sleep apnea and other respiratory disorders is on the rise in the U.S., primarily due to factors such as obesity, sedentary lifestyles, and an aging population. According to the Centers for Disease Control and Prevention (CDC) estimates published in May 2024, between August 2021 and August 2023, the obesity rate among adults was 40.3%, with no notable differences between women & men. Obesity was higher in adults aged 41-60 compared to those aged 20-39 and those 60 and older. This growing obesity rate contributes significantly to the increasing prevalence of sleep apnea, thereby driving the demand for CPAP devices.
Moreover, continuous innovations in CPAP technology have significantly enhanced patient comfort and therapy effectiveness. Modern CPAP machines feature quieter motors, compact designs, integrated humidification systems, and advanced data-tracking capabilities. These improvements address common patient concerns, such as noise and discomfort, thereby increasing therapy adherence rates.
Government health agencies and non-profit organizations frequently conduct public awareness initiatives to inform individuals about sleep apnea and treatment needs. For instance, in May 2024, the CDC in the U.S. incorporated sleep apnea into its broader public health campaigns on sleep hygiene and the management of chronic diseases.
The rental model plays a significant role in shaping the adoption of continuous positive airway pressure devices in the U.S., as well as pricing and revenue dynamics. CPAP devices are commonly provided to patients on a rent-to-own basis, typically over a 10 to 13-month period, driven largely by insurance reimbursement policies, including those of Medicare and private payers. In addition, this model reduces upfront costs for patients, enhances therapy initiation rates, and enables payers to verify compliance before full ownership, thereby facilitating broader market penetration.
However, it also slows immediate device sales revenue recognition for manufacturers, shifts purchasing power toward DME providers, and increases the importance of long-term patient adherence, remote monitoring, and replacement cycles (such as masks, tubing, and filters). CPAP rentals contribute to steady, recurring demand, greater price sensitivity, and stronger emphasis on connected devices and service-based differentiation in the U.S. continuous positive airway pressure (CPAP) devices industry.
This product will be delivered within 1-3 business days.
For instance, Medicare covers a 3-month trial of CPAP devices and accessories for individuals diagnosed with obstructive sleep apnea. The incidence of sleep apnea and other respiratory disorders is on the rise in the U.S., primarily due to factors such as obesity, sedentary lifestyles, and an aging population. According to the Centers for Disease Control and Prevention (CDC) estimates published in May 2024, between August 2021 and August 2023, the obesity rate among adults was 40.3%, with no notable differences between women & men. Obesity was higher in adults aged 41-60 compared to those aged 20-39 and those 60 and older. This growing obesity rate contributes significantly to the increasing prevalence of sleep apnea, thereby driving the demand for CPAP devices.
Moreover, continuous innovations in CPAP technology have significantly enhanced patient comfort and therapy effectiveness. Modern CPAP machines feature quieter motors, compact designs, integrated humidification systems, and advanced data-tracking capabilities. These improvements address common patient concerns, such as noise and discomfort, thereby increasing therapy adherence rates.
Government health agencies and non-profit organizations frequently conduct public awareness initiatives to inform individuals about sleep apnea and treatment needs. For instance, in May 2024, the CDC in the U.S. incorporated sleep apnea into its broader public health campaigns on sleep hygiene and the management of chronic diseases.
The rental model plays a significant role in shaping the adoption of continuous positive airway pressure devices in the U.S., as well as pricing and revenue dynamics. CPAP devices are commonly provided to patients on a rent-to-own basis, typically over a 10 to 13-month period, driven largely by insurance reimbursement policies, including those of Medicare and private payers. In addition, this model reduces upfront costs for patients, enhances therapy initiation rates, and enables payers to verify compliance before full ownership, thereby facilitating broader market penetration.
However, it also slows immediate device sales revenue recognition for manufacturers, shifts purchasing power toward DME providers, and increases the importance of long-term patient adherence, remote monitoring, and replacement cycles (such as masks, tubing, and filters). CPAP rentals contribute to steady, recurring demand, greater price sensitivity, and stronger emphasis on connected devices and service-based differentiation in the U.S. continuous positive airway pressure (CPAP) devices industry.
U.S. Continuous Positive Airway Pressure Devices Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2026 to 2033. For this study, the analyst has segmented the U.S. continuous positive airway pressure devices market report based on connectivity and end use.- Connectivity Outlook (Volume, 000' Units; Revenue, USD Million, 2021-2033)
- Connected
- Non-Connected
- End Use Outlook (Volume, 000' Units; Revenue, USD Million, 2021-2033)
- Home Care Settings
- Hospitals & Clinics
- Others (Long-Term Care Facilities, etc.)
Why You Should Buy This Report
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Market Variables, Trends, & Scope
Chapter 4. U.S. CPAP Devices Market: Connectivity Estimates & Trend Analysis
Chapter 5. U.S. CPAP Devices Market: End Use Estimates & Trend Analysis
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The leading players profiled in this U.S. Continuous Positive Airway Pressure Devices market report include:- ResMed
- Koninklijke Philips N.V.
- Fisher & Paykel Healthcare Limited
- React Health (3B Medical)
- Löwenstein Medical
- BMC Medical
- Wellell (Apex Medical)
- Armstrong Medical
- Breas Medical
- SEFAM
- Transcend Inc. (Somnetics International, Inc.)
- Trudell Medical (Vyaire)
- Medical Depot, Inc. dba Drive DeVilbiss Healthcare
- Invacare Corporation
- Apria Healthcare Group LLC
- Rotech Healthcare Inc.
- Lincare Holdings Inc.
- Rotech Healthcare Inc.
- adaptHealth
- Aeroflow Health
- CPAP.com
- AHOM
- The CPAP Shop
- Sleep Direct
- Edgepark Medical Supplies
- Apria Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | January 2026 |
| Forecast Period | 2025 - 2033 |
| Estimated Market Value ( USD | $ 1.35 Billion |
| Forecasted Market Value ( USD | $ 2.07 Billion |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | United States |
| No. of Companies Mentioned | 26 |
